Inventor
WALLNER BARBARA P
US30 patents
⚠️ This page may combine multiple inventors who share the name “WALLNER BARBARA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
16 patentsUS6162432ADec 19, 2000
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
BIOGEN INC159 citations98
US5223394AJun 29, 1993
Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence
BIOGEN INC63 citations96
US5547853AAug 20, 1996
CD2-binding domain of lymphocyte function associated antigen 3
BIOGEN INC66 citations95
US6764681B2Jul 20, 2004
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
BIOGEN INC39 citations92
US5928643AJul 27, 1999
Method of using CD2-binding domain of lymphocyte function associated antigen 3 to initiate T cell activation
BIOGEN INC24 citations92
US5914111AJun 22, 1999
CD2-binding domain of lymphocyte function associated antigen-3
BIOGEN INC30 citations92
US5728677AMar 17, 1998
Methods of inhibiting T-cell dependent proliferation of peripheral blood lymphocytes using the CD2-binding domain of lymphocyte function associated antigen 3
BIOGEN INC20 citations92
US4956281ASep 11, 1990
DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
BIOGEN INC108 citations92
US4879224ANov 7, 1989
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
BIOGEN INC44 citations92
US5484711AJan 16, 1996
DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI
BIOGEN INC18 citations82
US5185441AFeb 9, 1993
Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
BIOGEN INC16 citations82
US5298489AMar 29, 1994
DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI
BIOGEN INC8 citations74
US5081019AJan 14, 1992
DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
BIOGEN INC14 citations74
US4874743AOct 17, 1989
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
BIOGEN INC13 citations74
US4950646AAug 21, 1990
DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides
BIOGEN INC14 citations70
US5354665AOct 11, 1994
Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
BIOGEN INC2 citations62
POINT THERAPEUTICS INC
9 patentsUS6890904B1May 10, 2005
Anti-tumor agents
POINT THERAPEUTICS INC85 citations97
US6300314B1Oct 9, 2001
Hematopoietic stimulation
POINT THERAPEUTICS INC106 citations97
US7282484B2Oct 16, 2007
Anti-tumor agents
POINT THERAPEUTICS INC14 citations92
US7259138B2Aug 21, 2007
Anti-tumor agents
POINT THERAPEUTICS INC11 citations92
US6979697B1Dec 27, 2005
Regulation of substrate activity
POINT THERAPEUTICS INC23 citations92
US7067489B2Jun 27, 2006
Hematopoietic stimulation
POINT THERAPEUTICS INC14 citations91
US6770628B2Aug 3, 2004
Hematopoietic stimulation
POINT THERAPEUTICS INC34 citations91
US7276371B2Oct 2, 2007
Stimulation of hematopoietic cells in vitro
POINT THERAPEUTICS INC8 citations71
US7265118B2Sep 4, 2007
Regulation of substrate activity
POINT THERAPEUTICS INC3 citations63